Seres Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-62.9M | $-64.8M | $1.9M | $16.6M |
| FY2019 | $-76.5M | $-77.5M | $1.0M | $8.3M |
| FY2020 | $-93.6M | $-94.2M | $591.0K | $8.8M |
| FY2021 | $6.7M | $-2.9M | $9.6M | $20.2M |
| FY2022 | $-228.8M | $-238.6M | $9.8M | $25.5M |